Collagenous colitis presenting after orthotopic liver transplantation for α-1-antitrypsin deficiency

Digestive Diseases and Sciences

Volumn 52, Issue 1, 2007, Pages 217-219

  Halsey, Kevin ^a   Reichelderfer, Mark ^a   Callicott, Rod W ^a   Schwartz, Darren C ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b H6/516 ^*  (United States)

Author keywords

Collagenous colitis; Immunosuppression; Microscopic colitis; Transplantation

Indexed keywords

ALPHA 1 ANTITRYPSIN; ATROPINE PLUS DIPHENOXYLATE; COLESTYRAMINE; MESALAZINE; PREDNISONE; TACROLIMUS;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNITY; CASE REPORT; COLLAGENOUS COLITIS; COLON BIOPSY; COLONOSCOPY; DIARRHEA; DISEASE DURATION; DRUG TREATMENT FAILURE; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT RESPONSE;

ALPHA 1-ANTITRYPSIN DEFICIENCY; COLITIS; COLLAGEN; COLON; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER TRANSPLANTATION; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 33846290747     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9414-8     Document Type: Article

References (20)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429
2. Gow PJ, Chapman RW (2000) Liver transplantation for primary sclerosing cholangitis. Liver 20:97-103
3. Shaked A, Colonna JO, Goldstein L, Busuttil RW (1992) The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 215:598-605
4. Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Folkert BO, Kalayoglu M (1995) Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 118:615-620
5. Gavaler JS, Delemos B, Belle SH, Heyl AE, Tarter RE, Starzl TE, Gavaler C, Van Thiel DH (1991) Ulcerative colitis disease activity as a subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Digestive Diseases and Sciences 36:321-328
6. Befeler AS, Lissoos TW, Schiano TD, Conjeevaram H, Dasgupta KA, Millis JM, Newell KA, Thistlethwaite JR, Baker AL (1998) Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 65:393-396
7. Stephens J, Goldstein R, Crippin F, Husberg B, Holman M, Gonwa TA, Klintmalm G (1993) Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc 25:1122-1123
8. Broome U, Glaumann H, Hellers G, Nilsson B, Sorstad J, Hultcrantz R (1994) Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 35:84-89
9. Riley TR, Schoen RE, Lee RG, Rakela J (1997) A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol 92:279-282
10. Armes J, Gee DC, Macrae FA, Schroeder W, Bhathal PS (1992) Collagenous colitis: jejunal and colorectal pathology. J Clin Pathol 45:784-787
11. Bayless TM, Giardiello FM, Lazenby A, Yardley JH (1987) Collagenous colitis. Mayo Clin Proc 62:665-671
12. Haagsma EB, Van Den Berg AP, Kleibeuker JH, Slooff MJH, Dijkstra G (2003) Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. Aliment Pharmacol Ther 18:33-44
13. Rostaing L, Puyoo O, Tkaczuk J, Peres C, Rouzaud A, Cisterne JM, de Preval C, Ohayon E, Durand D, Abbal M (1999) Differences in type 1 and type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs tacrolimus) in stable renal allograft recipients. Clin Transplant 13:400-409
14. Targan S, Hanauer S, Van Deventer SJH, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ (1997) A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337:1029-1035
15. Neurath MF, Becker C, Barbulescu K (1998) Role of NF(kappa)B in immune and inflammatory responses in the gut. Gut 43:856-860
16. Kam L, Targan SR (1999) Cytokine-based therapies in inflammatory bowel disease. Curr Opin Gastroenterology 15:302-307
17. Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K, Burroughs AK (1998) Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 43:639-644
18. Alnoor R, Owen DA, Siegfried RE, Scudamore CH, Yoshida EM (2002) Post-liver transplant crohn's disease: graft tolerance but not self tolerance? Dig Dis Sci 47:522-527
19. Fernandez-Banares F, Salas A, Forne M, Esteve M, Espinos J, Viver JM (1999) Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 94:418-423
20. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C (2004) Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebo, Sweden, 1993-1998. Gut 53:346-350